Arev Life Sciences Global (AREVF) Stock Price, News & Analysis
Company Description
Arev Life Sciences Global (OTC Link: AREVF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $317.6K.
AREVF has declined 95.0% over the past year. Shares last traded at $0.0005.
This page collects what Stock Titan holds for AREVF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Arev Life Sciences Global (AREVF) stock last closed at $0.0005. Over the past 12 months, the stock has lost 95.0%. At a market capitalization of $317.6K, AREVF is classified as a micro-cap stock with approximately 31.8M shares outstanding.
Latest News
Arev Life Sciences Global has 4 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. View all AREVF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AREVF Company Profile & Sector Positioning
Arev Life Sciences Global (AREVF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing AREVF often look at related companies in the same sector, including Indoor Harvest (INQD), Lowell Farms (LOWLF), Transglobal Asse (TMSH), Canaquest Medica (CANQF), and Alterola Biotech (ABTI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AREVF's relative position within its industry.